To include your compound in the COVID-19 Resource Center, submit it here.

Vernalis gets another CRL in cough and cold pipeline

Vernalis plc (LSE:VER) lost 2p (11%) to 17p Monday after it said FDA issued a complete response

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE